HEMATOPATHOLOGY OF THE SKIN. CLINICAL AND PATHOLOGICAL APPROACH. 2ND EDITION

Part I Immunobiology and Molecular Pathogenesis
1 Cutaneous T-cell immunobiology
2 Cutaneous B-cell immunobiology
3 NK cell immunobiology
4 Mononuclear phagocytic system of the skin-guide to pathologists
5 Mast cells in the skin
6 Molecular pathogenesis of primary cutaneous T-cell lymphomas
7 Molecular pathogenesis of primary cutaneous B-cell lymphomas
Part II Laboratory Techniques
8 Flow cytometric analysis in hematopathology diagnosis
9 PCR-based gene rearrangement studies
10 FISH and cytogenetic techniques
11 Next-generation sequencing
Part III Primary Cutaneous T-Cell Lymphomas
12 Approach to the diagnosis of primary cutaneous T-cell lymphomas
13 Mycosis fungoides
14 Sézary syndrome
15 Primary cutaneous CD30-positive T-cell lymphoproliferative disorders
16 Subcutaneous panniculitis-like T-cell lymphoma
17 Cutaneous CD4+ small to medium lymphoproliferative disorder and other proliferations with TFH phenotype
18 Aggressive cytotoxic primary cutaneous T-cell lymphomas
19 Primary cutaneous peripheral T-cell lymphoma, not otherwise specified
20 Primary cutaneous CD8+ acral lymphoproliferative disorder
21 Granulomatous CD8-positive lymphoproliferative disorder associated with immunodeficiency
22 An approach to the treatment of mycosis fungoides/Sézary syndrome and CD30 positive lymphoproliferative disorders
Part IV Primary Cutaneous NK/T-Cell Malignancies
23 Extranodal natural killer/T-cell lymphoma, nasal type
24 Hydroa vacciniforme lymphoproliferative disorder
25 Natural killer-cell leukemias/lymphomas
Part V Systemic T- and NK-Cell Lymphomas With Cutaneous Dissemination
26 Systemic anaplastic large cell lymphoma
27 T-cell prolymphocytic leukemia
28 Skin manifestations of angioimmunoblastic T-cell lymphoma
29 Adult T-cell leukemia/lymphoma
Part VI Primary Cutaneous B-Cell Lymphoproliferative Disorders
30 Approach to the diagnosis of cutaneous B-cell lymphomas
31 Primary cutaneous follicle center B-cell lymphoma
32 Primary cutaneous marginal zone B-cell lymphoma
33 Primary cutaneous diffuse large B-cell lymphoma
34 Lymphomatoid granulomatosis
35 Mucocutaneous EBV- and HHV-8 associated lymphoproliferative disorders in acquired immunodeficiency
36 An approach to the treatment of primary cutaneous B-Cell lymphomas
Part VII Systemic B-Cell Lymphomas With Cutaneous Dissemination
37 Systemic follicular lymphoma, marginal zone lymphomas, and lymphoplasmacytic lymphoma
38 Intravascular large B-cell lymphoma
39 Cutaneous involvement in systemic diffuse large B-cell lymphomas
40 Cutaneous mantle cell lymphoma
41 Cutaneous manifestations of chronic lymphocytic leukemia/small lymphocytic lymphoma
42 Cutaneous plasma-cell neoplasms
43 Cutaneous involvement by Hodgkin""s lymphoma
Part VIII Cutaneous Reactive Infiltrates
44 Pityriasis lichenoides chronica
45 Jessner lymphocytic infiltrate and tumid lupus erythematosus
46 Pigmented purpuric dermatoses
47 Chronic actinic dermatitis_actinic reticuloid
48 CD30 pseudolymphomas
49 Pseudolymphomatous reactions with associated cutaneous neoplastic proliferations
50 Cutaneous lymphoid hyperplasia and related entities
51 Pseudolymphomas at sites of vaccination and in tattoos
52 Lymphoid proliferations in association with viral and bacterial infections
53 Cutaneous plasmacytosis
54 Cutaneous IgG4-related disease
55 Lymphomatoid contact dermatitis
56 Annular lichenoid dermatosis of youth
57 Eosinophilic dermatosis of hematologic malignancy
Part IX Precursor Lymphoid and Myeloid Neoplasms
58 Precursor B- and T-cell neoplasms
59 Leukemia cutis/aleukemic leukemia cutis/myeloid sarcoma
60 Cutaneous manifestations of myeloproliferative neoplasms
61 Cutaneous extramedullary hematopoiesis
62 Blastic plasmacytoid dendritic cell neoplasm
Part X Cutaneous Mast Cell Proliferations
63 Mast cell neoplasms
Part XI Benign and Malignant Histiocytic Disorders
64 Molecular classification of histiocytoses
65 Langerhans cell proliferations and related disorders ("L" group)
66 Rosai-Dorfman disease
67 Non-Langerhans cell histiocytoses (C and H groups)
68 Histiocytic and dendritic cell sarcomas
69 Intralymphatic histiocytosis and Melkersson-Rosenthal syndrome
Part XII Lymphoid Proliferations of Special Sites/Special Populations
70 Oral lymphoproliferative disorders
71 Ocular lymphoproliferative disorders
72 Cutaneous hematolymphoid proliferations in children
73 Alopecia in lymphoproliferative disorders
74 Cutaneous adverse reactions to chemotherapeutic agents
75 Cutaneous adverse reactions to immunotherapy
Part XIII Cutaneous Manifestations Associated With Hematologic Malignancy
76 Sweet and histiocytoid sweet syndrome
77 Wells syndrome (eosinophilic cellulitis)
78 Vasculitis
79 Paraneoplastic pemphigus
80 Cryoglobulinemia
81 Granulomatous reactions
82 Pyoderma gangrenosum
83 Schnitzler syndrome

The most comprehensive reference book on diagnosing cutaneous hematologic disorders available, Hematopathology of the Skin: Clinical and Pathological Approach, 2nd Edition, provides interdisciplinary guidance from more than 40 global experts in the fields of dermatopathology, dermatology, hematopathology, and hemato/oncology. Edited by Dr. Alejandro A. Gru, Dr. András Schaffer, and Dr. Alistair Robson, this concise yet comprehensive reference features a logical, consistent format heavily illustrated with high-quality clinical and pathological images throughout. Unparalleled in scope, it is a well-written, easy-to-follow resource for clinicians who care for patients with cutaneous hematologic neoplasms.
• Emphasizes cutaneous inflammatory conditions and reactive lymphoproliferations that resemble hematologic malignancies and often cause diagnostic dilemmas
• Includes new editorial board member Dr. Alistair Robson, a globally recognized world expert on skin lymphomas
• Uses a consistent chapter format that covers disease definition; clinical, histological, immunophenotypic, and genetic findings; detailed molecular and immune pathogenesis; detailed differential diagnoses; and a capsule summary
• Features hundreds of high-quality clinical and pathological images, tables, and figures that clearly explain key concepts
• Follows the classification guidelines of the World Health Organization and European Organization for Research and Treatment of Cancer (EORTC)
• Contains the most recent (2022) updates to WHO and EORTC classifications as well as an increased number of international contributing authors

Enrich Your eBook Reading Experience
• Read directly on your preferred device(s), such as computer, tablet, or smartphone.
• Easily convert to audiobook, powering your content with natural language text-to-speech.